Abstract
Adrenocortical carcinoma (AC) is a rare tumor with poor prognosis. Twenty-two patients (14 F, 8 M; age 22 to 59 years; median, 43 years) with AC were evaluated prospectively in a single center: tumor stage was I–II in 12 cases and III–IV in 10. The overall survival in our cohort was 41.6 ± 42 months; 16 subjects are still alive. Curative surgery was followed by longer survival than debulking or no surgery (p < 0.0001). The first relapse was highly predictive for further recurrences. Recurrent ACs were progressively more aggressive, and they occurred with variable but ever shorter intervals. At diagnosis, 14 patients (63.5%) presented with features of clear adrenocortical hyperactivity. Despite the absence of clinical signs of hormonal excess, all other patients presented some abnormalities of steroid secretion. The most common clinical finding was a recent diagnosis of moderate-to-severe hypertension (68%), poorly controlled by pharmacological treatment, often associated with multiple cardiovascular risk factors. High mitotic rate and undifferentiated polymorph cellular pattern were associated with worse prognosis. Response to treatments other than surgery (mitotane chemotherapy) was better in patients treated early after the first surgery. In conclusion, curative surgery was the most effective treatment. Monitoring arterial pressure, endocrine parameters, and metabolic parameters can be helpful for the early detection of AC recurrences.
Similar content being viewed by others
References
NH Hanna E Kenady (2000) ArticleTitleAdvances in the management of adrenal tumours Curr. Opin. Oncol. 11 49–53 Occurrence Handle10.1097/00001622-200001000-00008
NW Thompson PSY Cheung (1987) ArticleTitleDiagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas Surg. Clin. North Am. 67 423–436 Occurrence Handle1:STN:280:BiiC2sfmtVU%3D Occurrence Handle3551152
JA Søreide K Brabrand Sø Thoresen (1992) ArticleTitleAdrenal cortical carcinoma in Norway, 1970-1984 World J. Surg. 16 663–668 Occurrence Handle1413834
DA McFarlane (1958) ArticleTitleCancer of the adrenal cortex: The natural history, prognosis and treatment in a study of fifty-five cases Ann. R. Coll. Surg. Engl. 23 155 Occurrence Handle13571886
JP Luton S Cerdas L Billaud et al. (1990) ArticleTitleClinical features of adrenocortical carinoma, prognostic factors, and the effects of mitotane therapy N. Engl. J. Med. 322 1195–1201 Occurrence Handle1:STN:280:By%2BB38%2Fns1M%3D Occurrence Handle2325710
DJ Henley JA Heerden Particlevan CS Grant et al. (1983) ArticleTitleAdrenal cortical carcinoma: a continuing challenge Surgery 94 926–931 Occurrence Handle1:STN:280:BiuD2sznt1c%3D Occurrence Handle6648806
RA Decker ME Kuehner (1991) ArticleTitleAdrenocortical carcinoma Am. Surg. 57 502–513 Occurrence Handle1:STN:280:By2D38jhvFE%3D Occurrence Handle1928992
P Icard P Goudet C Charpenay et al. (2001) ArticleTitleAdrenocortical carcinomas: surgical trends and results of a 253 patient series from the French Association of Endocrine Surgeons study group World J. Surg. 25 891–897 Occurrence Handle10.1007/s00268-001-0047-y Occurrence Handle1:STN:280:DC%2BD3MrisVGisg%3D%3D Occurrence Handle11572030
R Vassilopoulou-Sellin PN Schultz (2001) ArticleTitleAdrenocortical carcinoma. Clinical outcome at the end of the 20th century Cancer 92 1113–1121 Occurrence Handle10.1002/1097-0142(20010901)92:5<1113::AID-CNCR1428>3.0.CO;2-I Occurrence Handle1:STN:280:DC%2BD3Mritl2isQ%3D%3D Occurrence Handle11571723
F Mantero M Terzolo G Arnaldi et al. (2000) ArticleTitleSurvey on adrenal incidentaloma in Italy J. Clin. Endocrinol. Metab. 85 637–644 Occurrence Handle10.1210/jc.85.2.637 Occurrence Handle1:CAS:528:DC%2BD3cXhtlyhurw%3D Occurrence Handle10690869
L Zarrilli LA Marzano L Tauchmanovà et al. (1999) ArticleTitleIncidentalomi surrenalici: risultato di uno studio prospettico di 100 casi. Focus – La chirurgia dei surreni oggi. Ospedali d’Italia Chirurgia (Bucur). 5 655–659
BL Wajchenberg MA Albergaria-Pereira et al. (2000) ArticleTitleAdrenocortical carcinoma: clinical and laboratory observation Cancer 88 711–736 Occurrence Handle10.1002/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.3.CO;2-N Occurrence Handle1:STN:280:DC%2BD3c7ksFKqtA%3D%3D Occurrence Handle10679640
Ch Bertagna DN Orth (1981) ArticleTitleClinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978) Review. Am J Med 71 855–875 Occurrence Handle10.1016/0002-9343(81)90384-3 Occurrence Handle1:STN:280:Bi2D28rlslM%3D
G Chrousos (1999) ArticleTitleRecent advances in diagnostic and therapeutic strategies.. In Bornstein SR, moderator, Adrenocortical tumors: recent advances in basic concepts and clinical management Ann. Intern. Med. 30 764–771
AC Latronico GP Chrousos (1997) ArticleTitleExtensive personal experience: adrenocortical tumors J. Clin. Endocrinol. Metab. 82 1317–1324 Occurrence Handle10.1210/jc.82.5.1317 Occurrence Handle1:CAS:528:DyaK2sXjtVGmtL0%3D Occurrence Handle9141510
A Stojadinovic RA Ghossein A Hoos et al. (2002) ArticleTitleAdrenocortical carcinoma: clinical, morphologic, and molecular characterization J. Clin. Oncol. 20 941–950 Occurrence Handle10.1200/JCO.20.4.941 Occurrence Handle1:CAS:528:DC%2BD38XitFOqtbo%3D Occurrence Handle11844815
H Sasano T Suzuki T Moriya (2001) ArticleTitleDiscerning malignancy in resected adrenocortical neoplasms Endocr. Pathol. 12 397–406 Occurrence Handle10.1385/EP:12:4:397 Occurrence Handle1:STN:280:DC%2BD387otFymsw%3D%3D Occurrence Handle11914473
AM Hutter SuffixJr DE Kayhoe (1966) ArticleTitleAdrenal cortical carcinoma: clinical features in 138 patients Am. J. Med. 41 572–580 Occurrence Handle10.1016/0002-9343(66)90219-1 Occurrence Handle5923598
M Sullivan M Boileau CV Hodges (1978) ArticleTitleAdrenal cortical carcinoma J. Urol. 120 660–665 Occurrence Handle1:STN:280:CSaD1M7kvVw%3D Occurrence Handle731800
LM Weiss (1984) ArticleTitleComparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors Am. J. Surg. Pathol. 8 163–169 Occurrence Handle1:STN:280:BiuC2M7ktlI%3D Occurrence Handle6703192
LM Weiss LJ Medeiros AL Vickety SuffixJr (1989) ArticleTitlePathologic features of prognostic significance in adrenocortical carcinoma Am. J. Surg. Pathol. 13 202–206 Occurrence Handle1:STN:280:BiaC2cflsVA%3D Occurrence Handle2919718
R Rossi L Tauchmanovà A Luciano et al. (2000) ArticleTitleSubclinical Cushing’s syndrome in patients with adrenal incidentaloma. Clinical and biochemical features J. Clin. Endocrinol. Metab. 85 1440–1448 Occurrence Handle10.1210/jc.85.4.1440 Occurrence Handle1:CAS:528:DC%2BD3cXisFOqtbg%3D Occurrence Handle10770179
J Rosai (1996) Adrenal gland and other paraganglia R Rosai (Eds) Ackerman’s surgical pathology EditionNumbervol 1, 8th edition Mosby St. Louis
A Kasperlik-Zaluska BM Migdalska S Zglicznski et al. (1995) ArticleTitleAdrenocortical carcinoma. A clinical study and treatment result of 52 patients Cancer 75 2587–2591 Occurrence Handle1:STN:280:ByqB2MvksFQ%3D Occurrence Handle7736405
MD Wooten DK King (1993) ArticleTitleAdrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature Cancer 72 3145–3155 Occurrence Handle1:STN:280:ByuD287nsVc%3D Occurrence Handle8242539
TJ McKenna RB Miller GW Liddle (1977) ArticleTitlePlasma pregnenolone and 17-OH-pregnenolone in patients with adrenal tumors, ACTH excess or idiopathic hirsutism J. Clin. Endocrinol. Metab. 44 231–234 Occurrence Handle1:STN:280:CSiC3Mfos10%3D Occurrence Handle190251
BB Medonca AM Lucon CA Menezes et al. (1995) ArticleTitleClinical, hormonal and pathological findings in a comparative study of adrenal cortical neoplasms in childhood and adulthood J. Urol. 154 2004–2009 Occurrence Handle10.1097/00005392-199512000-00006 Occurrence Handle7500445
TB Kaye L Crapo (1990) ArticleTitleThe Cushing’s syndrome: an update on diagnostic tests Ann. Intern. Med. 112 434–444 Occurrence Handle1:STN:280:By%2BC2sfovF0%3D Occurrence Handle2178536
M Reincke J Nieke GP Krestin et al. (1992) ArticleTitlePreclinical Cushing’s syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing’s syndrome J. Clin. Endocrinol. Metab. 75 826–832 Occurrence Handle10.1210/jc.75.3.826 Occurrence Handle1:STN:280:By2A1cfjs1M%3D Occurrence Handle1517373
B Ambrosi A Sartorio A Pizzocaro et al. (2000) ArticleTitleEvaluation of haemostatic and fibrinolytic markers in patients with Cushing’s syndrome and in patients with adrenal incidentaloma Exp. Clin. Endocrinol. Diabetes 108 294–298 Occurrence Handle10.1055/s-2000-8000 Occurrence Handle1:CAS:528:DC%2BD3MXhs1Kjurk%3D Occurrence Handle10961361
L Barzon P Zucchetta M Boscaro et al. (2001) ArticleTitleScintigraphic pattern of adrenocortical carcinoma: morpho-functional correlates Eur. J. Endocrinol. 145 743–748 Occurrence Handle1:CAS:528:DC%2BD3MXpt1Ght7c%3D Occurrence Handle11720899
RF Pommier MF Brennan (1992) ArticleTitleAn eleven-year experience with adrenocortical carcinoma Surgery 112 963–970 Occurrence Handle1:STN:280:ByyD1cfhslY%3D Occurrence Handle1455321
HR Haak J Hermans CJ Velde Particlevan de et al. (1994) ArticleTitleOptimal treatment of adrenocortical carcinoma with mitotane : results in a consecutive series of 96 patients Br. J. Cancer 69 947–951 Occurrence Handle1:STN:280:ByuB3srksFA%3D Occurrence Handle8180029
A Khoram-Manesh H Ahlman S Jansson et al. (1998) ArticleTitleAdrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up World J. Surg. 2 605–611 Occurrence Handle10.1007/s002689900442
M Terzolo A Anna-Pia A Berruti et al. (2000) ArticleTitleLow-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer J. Clin. Endocrinol. Metab. 85 2234–2238 Occurrence Handle10.1210/jc.85.6.2234 Occurrence Handle1:CAS:528:DC%2BD3cXlsVCjsr4%3D Occurrence Handle10852456
DE Schteingart (1992) ArticleTitleTreating adrenal cancer Endocrinologist 2 149–157
SE Bates CY Shieh LA Mickley et al. (1991) ArticleTitleMitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/p-glycoprotein) which is also expressed by adrenocortical carcinomas J. Clin. Endocrinol. Metab. 73 18–29 Occurrence Handle1675220
H Ahlman A Khorram-Manesh S Jansson et al. (2001) ArticleTitleCytotoxic treatment of adrenocortical carcinoma World J. Surg. 25 927–933 Occurrence Handle10.1007/s00268-001-0031-6 Occurrence Handle1:STN:280:DC%2BD3MrisVGitg%3D%3D Occurrence Handle11572034
TF Hogan KW Gilchrist DW Westring et al. (1980) ArticleTitleA clinical and pathological study of adrenocortical carcinoma: therapeutic implications Cancer 45 2880–2883 Occurrence Handle1:STN:280:Bi%2BC1MbmvF0%3D Occurrence Handle7379017
C Wachenfeld F Beuschlein O Zwermann et al. (2001) ArticleTitleDiscerning malignancy in adrenocortical tumors: are molecular markers useful? Eur. J. Endocrinol. 145 335–341 Occurrence Handle1:CAS:528:DC%2BD3MXmslGkt7c%3D Occurrence Handle11517015
BL Wajchenberg MA Pereira BB Medonca et al. (2000) ArticleTitleAdrenocortical carcinoma. Clinical and laboratory observations Cancer 88 711–736 Occurrence Handle10.1002/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.3.CO;2-N Occurrence Handle1:STN:280:DC%2BD3c7ksFKqtA%3D%3D Occurrence Handle10679640
Acknowledgments
The authors thank the many health professionals who cared for the patients with adrenocortical carcinoma over these years. They are also indebted to Dr Melania Pulcrano for organizing the database, Prof. Fimmanò, and Dr. Nicola Gennarelli for their help in the surgical care of some patients, and Mr. Angelo Di Francia for his skilled technical support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tauchmanovà, L., Colao, A., Marzano, L. et al. Andrenocortical Carcinomas: Twelve-year Prospective Experience. World J. Surg. 28, 896–903 (2004). https://doi.org/10.1007/s00268-004-7296-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-004-7296-5